Robin L Washington Insider Trading $GILD GILEAD SCIENCES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robin L Washington.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robin L Washington. Robin L Washington is Director in HONEYWELL INTERNATIONAL INC ($HON) and EVP, CFO in GILEAD SCIENCES INC ($GILD) and in TEKTRONIX INC ($TEK) and Director in TEKTRONIX INC ($TEK) and Director in SALESFORCE COM INC ($CRM) and Director in Alphabet Inc. ($GOOG, GOOG) and Director in Vertiv Holdings Co ($GSAH).
Robin L Washington in GILEAD SCIENCES INC
Trading Symbol: GILDIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Robin L Washington: EVP, CFO
Holdings: 21,620 shares
Current Value: $1,581,071
Latest Transaction: Mar 14 2019
$GILD Market Capitalization: $88.05B
$GILD Previous Close: $73.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Robin L Washington in GILEAD SCIENCES INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GOOG, GOOG, GILD, HON, CRM, TEK, GSAH
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 14 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | J | 0.00 | 330 | 0 | 117,323 | 117 K to 117.3 K (+0.28 %) |
Mar 14 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | J | 0.00 | 330 | 0 | 21,620 | 22 K to 21.6 K (-1.50 %) |
Mar 14 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 57.45 | 330 | 18,959 | 21,950 | 21.6 K to 22 K (+1.53 %) |
Mar 14 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | J | 0.00 | 11,588 | 0 | 116,993 | 105.4 K to 117 K (+10.99 %) |
Mar 14 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | J | 0.00 | 11,588 | 0 | 21,620 | 33.2 K to 21.6 K (-34.90 %) |
Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | A | 0.00 | 14,550 | 0 | 14,550 | |
Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | A | 68.75 | 67,310 | 4,627,563 | 67,310 | |
Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Payment of Exercise | F | 68.75 | 5,535 | 380,531 | 33,208 | 38.7 K to 33.2 K (-14.29 %) |
Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 8,270 | 0 | 38,743 | 30.5 K to 38.7 K (+27.14 %) |
Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 13,312 | 0 | 30,473 | 17.2 K to 30.5 K (+77.57 %) |
Mar 02 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 80.31 | 5,000 | 401,566 | 105,405 | 110.4 K to 105.4 K (-4.53 %) |
Mar 02 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 6,588 | 0 | 110,405 | 103.8 K to 110.4 K (+6.35 %) |
Mar 02 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 6,588 | 0 | 17,161 | 23.7 K to 17.2 K (-27.74 %) |
Mar 02 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 340 | 0 | 103,817 | 103.5 K to 103.8 K (+0.33 %) |
Mar 02 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 340 | 0 | 23,749 | 24.1 K to 23.7 K (-1.41 %) |
Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Payment of Exercise | F | 80.69 | 5,690 | 459,126 | 24,089 | 29.8 K to 24.1 K (-19.11 %) |
Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 5,183 | 0 | 29,779 | 24.6 K to 29.8 K (+21.07 %) |
Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 14,654 | 0 | 24,596 | 9.9 K to 24.6 K (+147.39 %) |
Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 62.35 | 340 | 21,198 | 9,942 | 9.6 K to 9.9 K (+3.54 %) |
Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | A | 83.49 | 100,650 | 8,403,269 | 100,650 | |
Sep 11 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 24.30 | 33,750 | 819,956 | 0 | |
Sep 11 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 85.00 | 18,070 | 1,535,950 | 103,477 | 121.5 K to 103.5 K (-14.87 %) |
Sep 11 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 85.00 | 33,750 | 2,868,750 | 9,602 | 43.4 K to 9.6 K (-77.85 %) |
Sep 11 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 24.30 | 33,750 | 819,956 | 43,352 | 9.6 K to 43.4 K (+351.49 %) |
Mar 02 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 11,804 | 0 | 121,547 | 109.7 K to 121.5 K (+10.76 %) |
Mar 02 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 11,804 | 0 | 9,602 | 21.4 K to 9.6 K (-55.14 %) |
Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Payment of Exercise | F | 70.31 | 7,814 | 549,402 | 21,406 | 29.2 K to 21.4 K (-26.74 %) |
Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 3,185 | 0 | 29,220 | 26 K to 29.2 K (+12.23 %) |
Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 4,516 | 0 | 26,035 | 21.5 K to 26 K (+20.99 %) |
Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 59.33 | 315 | 18,689 | 21,519 | 21.2 K to 21.5 K (+1.49 %) |
Feb 06 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | A | 72.25 | 101,740 | 7,350,715 | 101,740 | |
Aug 31 2016 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 3,225 | 0 | 109,743 | 113 K to 109.7 K (-2.85 %) |
Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | J | 0.00 | 28,280 | 0 | 21,204 | 49.5 K to 21.2 K (-57.15 %) |
Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | J | 0.00 | 28,280 | 0 | 112,968 | 84.7 K to 113 K (+33.39 %) |
Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 90.72 | 6,250 | 567,000 | 84,688 | 90.9 K to 84.7 K (-6.87 %) |
Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Payment of Exercise | F | 91.15 | 26,808 | 2,443,549 | 49,484 | 76.3 K to 49.5 K (-35.14 %) |
Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 35,174 | 0 | 76,292 | 41.1 K to 76.3 K (+85.54 %) |
Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 13,146 | 0 | 41,118 | 28 K to 41.1 K (+47.00 %) |
Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 76.02 | 248 | 18,854 | 27,972 | 27.7 K to 28 K (+0.89 %) |
Feb 03 2016 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | A | 84.05 | 68,600 | 5,765,830 | 68,600 | |
Nov 12 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 2,892 | 0 | 90,938 | 88 K to 90.9 K (+3.28 %) |
Nov 12 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 2,892 | 0 | 27,724 | 30.6 K to 27.7 K (-9.45 %) |
Nov 09 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 0.00 | 6,000 | 0 | 0 | |
Nov 09 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Payment of Exercise | F | 107.83 | 3,108 | 335,136 | 30,616 | 33.7 K to 30.6 K (-9.22 %) |
Nov 09 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 0.00 | 6,000 | 0 | 33,724 | 27.7 K to 33.7 K (+21.64 %) |
Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 109.61 | 4,350 | 476,806 | 88,046 | 92.4 K to 88 K (-4.71 %) |
Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 109.13 | 1,900 | 207,344 | 92,396 | 94.3 K to 92.4 K (-2.01 %) |
Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 103.41 | 100 | 10,341 | 94,296 | 94.4 K to 94.3 K (-0.11 %) |
Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 102.60 | 3,150 | 323,176 | 94,396 | 97.5 K to 94.4 K (-3.23 %) |
Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 101.75 | 3,000 | 305,261 | 97,546 | 100.5 K to 97.5 K (-2.98 %) |
Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 925 | 0 | 100,546 | 101.5 K to 100.5 K (-0.91 %) |
May 05 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 40.56 | 5,592 | 226,812 | 39,158 | |
May 05 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 24.30 | 11,250 | 273,319 | 33,750 | |
May 05 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 106.02 | 5,200 | 551,314 | 27,724 | 32.9 K to 27.7 K (-15.79 %) |
May 05 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 105.33 | 5,742 | 604,787 | 32,924 | 38.7 K to 32.9 K (-14.85 %) |
May 05 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 104.23 | 3,700 | 385,643 | 38,666 | 42.4 K to 38.7 K (-8.73 %) |
May 05 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 103.48 | 2,200 | 227,661 | 42,366 | 44.6 K to 42.4 K (-4.94 %) |
May 05 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 40.56 | 5,592 | 226,812 | 44,566 | 39 K to 44.6 K (+14.35 %) |
May 05 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 24.30 | 11,250 | 273,319 | 38,974 | 27.7 K to 39 K (+40.58 %) |
Feb 27 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 57,632 | 0 | 101,471 | 43.8 K to 101.5 K (+131.46 %) |
Feb 27 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 57,632 | 0 | 27,724 | 85.4 K to 27.7 K (-67.52 %) |
Page: 1